Document is current
Any future updates will be listed below
-
Authors
Allarakhia, Sabrina
Morra, Alison
Theal, Rebecca
Moloney, Max
Gupta, Samir
To, Teresa
Digby, Geneviève
Barber, David
Queenan, John
Lougheed, M. Diane
-
Funding
Funding for this research was provided by:
Government of Ontario’s Academic Health Sciences Centre Alternate Funding Plan Innovation Fund
- License Information
-
More Information
Article History
Received: 14 December 2024
Accepted: 20 October 2025
First Online: 26 November 2025
Competing interests
: In the past 3 years, M. Diane Lougheed has received grants outside the submitted work paid directly to Queen’s University from the Canadian Institutes of Health Research (sub-grants from Ottawa Health Research Institute and University of Toronto), Manitoba Workers Compensation Board, Astra Zeneca and GlaxoSmithKline; and an honorarium from AstraZeneca for participation in the Precision Program Advisory Board. She has also served as a member of Health Quality Ontario’s Asthma in Adults and Asthma in Children Quality Standard Advisory Committees. A. Morra has received honoraria for participation in a PRECISION Severe Asthma Summit Meeting from Astra Zeneca. G. Digby has received research funding from MaRS/Merck & Co Inc and from Pfizer Inc, as well as an honorarium from Merck & Co Inc for a speaking engagement and from AstraZeneca for participation in a working group. She has also received grants outside the submitted work paid directly to Queen’s University from the Ontario Lung Association and Ontario Thoracic Society. She serves as the Canadian Thoracic Society Choosing Wisely Canada Working Group chair.
